A process for preparing &ggr;-hydroxy-4-[[2-oxazolyl]alkyl]-&agr;-[(cyclo)alkyl- or aryl- or heteroaryl-substituted methyl]-2-[[(un)substituted alkyl]aminocarbonyl]-1-piperazinepentanamides is disclosed. The piperazinepentanamides are useful as HIV protease inhibitors. A process for making a 4-[[2-oxazolyl]alkyl]-2-[[(un)substituted alkyl]aminocarbonyl]piperazine by treating a ketoamide precursor with fuming sulfuric acid in the presence of polyphosphoric acid is also disclosed. In addition, a process for enhancing the optical purity of 4-[[2-oxazolyl]alkyl]-2-[[(un)substituted alkyl]aminocarbonyl]-piperazines via the formation 2-naphthalenesulfonic acid crystal salts thereof is disclosed, as well as a method for purifying 2-naphthalenesulfonic acid.
本发明公开了一种制备&ggr;-羟基-4-[[2-
噁唑基]烷基]-&agr;-[(环)烷基-或芳基-或杂环芳基取代的甲基]-2-[[(非)取代的烷基]
氨基甲酰-1-
哌嗪戊酰胺的方法。
哌嗪戊酰胺可用作HIV蛋白酶抑制剂。本发明还公开了一种通过在聚
磷酸存在下用浓
硫酸处理酮酰前体制备4-[[2-
噁唑基]烷基]-2-[[(非)取代的烷基]
氨基甲酰
哌嗪的方法。此外,本发明还公开了一种通过形成
2-萘磺酸晶体盐来增强4-[[2-
噁唑基]烷基]-2-[[(非)取代的烷基]
氨基甲酰
哌嗪的光学纯度的方法,以及一种纯化
2-萘磺酸的方法。